150 related articles for article (PubMed ID: 2454238)
1. Human cytokines, tumor necrosis factor, and interferons: gene cloning, animal studies, and clinical trials.
Bollon AP; Berent SL; Torczynski RM; Hill NO; Lemeshev Y; Hill JM; Jia FL; Joher A; Pichyangkul S; Khan A
J Cell Biochem; 1988 Apr; 36(4):353-67. PubMed ID: 2454238
[TBL] [Abstract][Full Text] [Related]
2. Endogenous production of tumor necrosis factor in normal mice and human cancer patients by interferons and other cytokines combined with biological response modifiers of bacterial origin.
Satoh M; Inagawa H; Shimada Y; Soma G; Oshima H; Mizuno D
J Biol Response Mod; 1987 Oct; 6(5):512-24. PubMed ID: 2445926
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 4 potentiates the antiproliferative effects of tumor necrosis factor on various tumor cell lines.
Totpal K; Aggarwal BB
Cancer Res; 1991 Aug; 51(16):4266-70. PubMed ID: 1651157
[TBL] [Abstract][Full Text] [Related]
4. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
[TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus type 1 alters transcript levels of tumor necrosis factor-alpha and interleukin-6 in retinal glial cells.
Drescher KM; Whittum-Hudson JA
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2302-12. PubMed ID: 8843914
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis of cultured mouse luteal cells induced by tumor necrosis factor-alpha and interferon-gamma.
Jo T; Tomiyama T; Ohashi K; Saji F; Tanizawa O; Ozaki M; Yamamoto R; Yamamoto T; Nishizawa Y; Terada N
Anat Rec; 1995 Jan; 241(1):70-6. PubMed ID: 7879925
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of interferon induction of class I major histocompatibility complex antigen expression by human tumor necrosis factor in small cell lung cancer cell lines.
Marley GM; Doyle LA; Ordóñez JV; Sisk A; Hussain A; Yen RW
Cancer Res; 1989 Nov; 49(22):6232-6. PubMed ID: 2553249
[TBL] [Abstract][Full Text] [Related]
8. Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cells.
Gemlo BT; Palladino MA; Jaffe HS; Espevik TP; Rayner AA
Cancer Res; 1988 Oct; 48(20):5864-7. PubMed ID: 3139285
[TBL] [Abstract][Full Text] [Related]
9. Lung-specific delivery of cytokines induces sustained pulmonary and systemic immunomodulation in rats.
Debs RJ; Fuchs HJ; Philip R; Montgomery AB; Brunette EN; Liggitt D; Patton JS; Shellito JE
J Immunol; 1988 May; 140(10):3482-8. PubMed ID: 3283235
[TBL] [Abstract][Full Text] [Related]
10. Overlapping polypeptide induction in human fibroblasts in response to treatment with interferon-alpha, interferon-gamma, interleukin 1 alpha, interleukin 1 beta, and tumor necrosis factor.
Beresini MH; Lempert MJ; Epstein LB
J Immunol; 1988 Jan; 140(2):485-93. PubMed ID: 3121746
[TBL] [Abstract][Full Text] [Related]
11. Regulatory mechanisms for production of IFN-gamma and TNF by antitumor T cells or macrophages in the tumor-bearing state.
Yamamoto N; Zou JP; Li XF; Takenaka H; Noda S; Fujii T; Ono S; Kobayashi Y; Mukaida N; Matsushima K
J Immunol; 1995 Mar; 154(5):2281-90. PubMed ID: 7868900
[TBL] [Abstract][Full Text] [Related]
12. Preclinical approaches to the treatment of metastatic disease: therapeutic properties of rH TNF, rM IFN-gamma, and rH IL-2.
Talmadge JE; Black PL; Tribble H; Pennington R; Bowersox O; Schneider M; Phillips H
Drugs Exp Clin Res; 1987; 13(6):327-37. PubMed ID: 3115744
[TBL] [Abstract][Full Text] [Related]
13. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
[TBL] [Abstract][Full Text] [Related]
14. Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products.
Elner SG; Elner VM; Bian ZM; Lukacs NW; Kurtz RM; Strieter RM; Kunkel SL
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):446-55. PubMed ID: 9040478
[TBL] [Abstract][Full Text] [Related]
15. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells.
Mori K; Stone S; Khaodhiar L; Braverman LE; DeVito WJ
J Cell Biochem; 1999 Aug; 74(2):211-9. PubMed ID: 10404391
[TBL] [Abstract][Full Text] [Related]
16. Cytolysis of tumor necrosis factor (TNF)-resistant tumor targets. Differential cytotoxicity of monocytes activated by the interferons, IL-2, and TNF.
Philip R
J Immunol; 1988 Feb; 140(4):1345-9. PubMed ID: 2449501
[TBL] [Abstract][Full Text] [Related]
17. Synergistic cooperation between T cell lymphokines for induction of the nitric oxide synthase gene in murine peritoneal macrophages.
Deng W; Thiel B; Tannenbaum CS; Hamilton TA; Stuehr DJ
J Immunol; 1993 Jul; 151(1):322-9. PubMed ID: 7686939
[TBL] [Abstract][Full Text] [Related]
18. Cell-associated human retinal pigment epithelium interleukin-8 and monocyte chemotactic protein-1: immunochemical and in-situ hybridization analyses.
Elner VM; Burnstine MA; Strieter RM; Kunkel SL; Elner SG
Exp Eye Res; 1997 Dec; 65(6):781-9. PubMed ID: 9441701
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous response of human colon cancer cells to the cytostatic and cytotoxic effects of recombinant human cytokines: interferon-alpha, interferon-gamma, tumor necrosis factor, and interleukin-1.
Morikawa K; Fidler IJ
J Biol Response Mod; 1989 Apr; 8(2):206-18. PubMed ID: 2499665
[TBL] [Abstract][Full Text] [Related]
20. Effect of human cytokines (IFN-gamma, TNF-alpha, IL-1 beta, IL-4) on porcine endothelial cells: induction of MHC and adhesion molecules and functional significance of these changes.
Batten P; Yacoub MH; Rose ML
Immunology; 1996 Jan; 87(1):127-33. PubMed ID: 8666424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]